| |||||||||||||
| Rating | Health Concerns |
|---|---|
![]() |
Hepatitis C (zinc-L-carnosine) |
![]() |
|
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary
studies suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but
minimal or no scientific evidence. For a supplement, little scientific support and/or minimal
health benefit. | |
Carnosine deficiency may occur in severe protein deficiency and in certain severe genetic disorders characterised by inborn errors in amino acid metabolism.
For eradication of H. pylori, the amount of the zinc carnosine complex used in research studies was 150 mg twice daily. Due to the lack of human clinical trials, recommended levels for other applications are not known at this time.
Due to the lack of human studies, side effects and interactions are not known.
At the time of writing, there were no well-known drug interactions with carnosine.
1. Quinn PJ, Boldyrev AA, Formazuyk VE. Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Med 1992;13:379-444.
2. Bonfanti L, Peretto P, De Marchis S, Fasolo A. Carnosine-related dipeptides in the mammalian brain. Prog Neurobiol 1999;59:333-53.
3. Klebanov GI, Teselkin YO, Babenkova IV. Effect of carnosine and its components on free-radical reactions. Membr Cell Biol 1998;12:89-99.
4. Hipkiss AR, Preston JE, Himsworth DT. Pluripotent protective effects of carnosine, a naturally occurring dipeptide. Ann NY Acad Sci 1998;854:37-53.
5. Hipkiss AR. Carnosine, a protective, anti-ageing peptide? Int J Biochem Cell Biol 1998;30:863-8.
6. Kudriashov IB, Deev LI, Goncharenko EN, et al. [Radioprotective properties of carnosine] Radiats Biol Radioecol 1999;39:268-71 [in Russian].
7. Lee JW, Miyawaki H, Bobst EV, et al. Improved functional recovery of ischemic rat hearts due to singlet oxygen scavengers histidine and carnosine. J Mol Cell Cardiol 1999;31:113-21.
8. Roberts PR, Black KW, Santamauro JT, Zaloga GP. Dietary peptides improve wound healing following surgery. Nutrition 1998;14;266-9.
9. Nishiwaki H, Kato S, Sugamoto S, et al. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc. J Physiol Pharmacol 1999;50:183-95.
10. Arakawa T, Satoh H, Nakamura A, et al. Effects of zinc L-carnosine on gastric mucosal and cell damage caused by ethanol in rats. Correlation with endogenous prostaglandin E2. Dig Dis Sci 1990;35:559-66.
11. Cho CH, Ogle CW. A correlative study of the antiulcer effects of zinc sulphate in stressed rats. Eur J Pharmacol 1978;48:97-105.
12. Frommer DJ. The healing of gastric ulcers by zinc sulphate. Med J Aust 1975;2:793-6.
13. Kashimura H, Suzuki K, Hassan M, et al. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:483-7.
14. Katayama S, Ohshita J, Sugaya K. New medicinal treatment for severe gingivostomatitis. Int J Mol Med 1998;2:675-9.
15. Takagi H, Nagamine T, Abe T, et al. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. J Viral Hepat 2001;8:367-71.
| |||||||